Delivery Order SPE2DE21D0007-SPE2D625F2H6U

Award Date 4/11/25
Potential Completion Date 5/1/25
Potential Value $1.8K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $4,418.30 fixed-price delivery order awarded to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer, by the Defense Health Agency for blood group serum supplies. The order has a period of performance ending on November 29, 2024. Ortho-Clinical Diagnostics is a for-profit organization and self-certified HUBZone joint venture that has previously provided medical equipment, reagents, and testing services to federal agencies including the Department of Veterans Affairs and...
This is a $849,897.70 firm fixed-price purchase order contract awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is for blood bank testing supplies and services, with a period of performance ending on September 30, 2028. The contract does not have a set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture that has been awarded multiple Indefinite...
This is a $1,255.63 fixed-price delivery order awarded by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer and self-certified HUBZone joint venture. The contract is for the supply of "ANTI-M 1X5ML" medical products, with a period of performance through April 23, 2025. The contract does not utilize a set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a key supplier of sophisticated...
This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Medical Supply Chain division of the Defense agency. The contract is for the delivery of Blood Group Serum 15S, with a ceiling value of $2,904.77 and a period of performance ending on May 7, 2025. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type. It does not have a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer located in Raritan, New Jersey. The contract has a ceiling value of $69,031.80 and is for the provision of unspecified "other medical" supplies. The contract has a firm fixed price pricing type and an ultimate completion date of April 16, 2026. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture and...
This is a federal contract award from the Medical Supply Chain (an alternate name for the Defense Agency), valued at $1,305.93, awarded to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is a Delivery Order, with a fixed price and economic price adjustment pricing type, and an ultimate completion date of June 20, 2025. It does not have a set-aside designation. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture that specializes...
This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Medical Supply Chain division of the Defense Department's Defense Health Agency. The $1,767.32 firm fixed-price delivery order is for the supply of 4,568,212,039 units of Anti-A,B Bioclone 15x10ml. The contract has a June 2, 2025 completion date and does not utilize a set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified...
This is a $106,717.41 firm-fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer self-certified as a HUBZone joint venture. The contract is for the provision of ORTHO-CLINICAL BLOOD ANALYZER REAGENTS and has an ultimate completion date of November 20, 2028. Ortho-Clinical Diagnostics, Inc. has demonstrated expertise in supplying specialized medical diagnostic equipment and consumables to...
This is a $1,832.54 delivery order awarded by the Medical Supply Chain, a division of the Defense agency, to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is for the supply of "ANTI-A BIOCLONE 15X10ML", a medical diagnostic product, with a period of performance through May 2025. The contract has a fixed price with economic price adjustment pricing type and does not utilize any set-aside designations. Ortho-Clinical Diagnostics, Inc. is a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for $71,850.72. The contract has an estimated completion date of April 30, 2025 and does not have a set-aside designation. Ortho-Clinical Diagnostics is a self-certified HUBZone joint venture that provides a range of diagnostic solutions, including COVID-19 tests and immunodiagnostic systems, to federal...
  • SPE2DE21D0007
    Indefinite Delivery Contract
  • SPE2DE21D0007-SPE2D625F2H6U
    Delivery Order

This is a $1,849.78 fixed-price delivery order awarded to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Defense Health Agency (DHA). The contract is for the provision of 4567880985 ! BLOOD GROUPING SERUM, with a period of performance ending on May 1, 2025. Ortho-Clinical Diagnostics is a self-certified HUBZone joint venture and a manufacturer of goods, primarily supplying critical medical diagnostic equipment and associated reagents to various federal healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, and other federal medical facilities. The contract does not have a set-aside designation, indicating open competition. Ortho-Clinical Diagnostics holds several significant Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) with federal agencies, demonstrating its capability to provide complex, long-term medical diagnostic equipment and service contracts across various federal healthcare systems.

Generated 7/11/25, 10:03 AM